Drug Trial Radar · NCT05646381
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Last checked: Nov 19, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
502
Planned (sponsor's estimate)
Start
Mar 7, 2024
Primary completion
Mar 12, 2030
Study completion Mar 12, 2030
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Dec 12, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) administered subcutaneously once monthly compared to placebo in slowing the progression of calcific aortic valve stenosis.
Conditions
- Aortic Stenosis
Interventions
Pelacarsen (TQJ230) 80mgDrug
Pelacarsen (TQJ230) 80mg
Matching placeboDrug
Matching placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in peak aortic jet velocityTime frame: 36 months
- Change in aortic valve calcium scoreTime frame: 36 months
Locations
140 sites in 15 countries. Site status is shown where the registry gives one.
Heart Center Research Llc
Huntsville, Alabama · Recruiting
Cardiovascular Res Found
Beverly Hills, California · Recruiting
National Heart Institute
Beverly Hills, California · Recruiting
Flourish Clinical Resrch Covin
Covina, California · Recruiting
Valley Clinical Trials
Northridge, California · Recruiting
Stanford University Medical Center
Palo Alto, California · Recruiting
University Of California San Diego
San Diego, California · Recruiting
UC San Francisco Medical Center
San Francisco, California · Recruiting
Excel Medical Clinical Trials LLC
Boca Raton, Florida · Withdrawn
Nova Clinical Research LLC
Bradenton, Florida · Recruiting
Flourish Res Acq LLC North Miami
Miami, Florida · Recruiting
Inpatient Research Clinical LLC
Miami Lakes, Florida · Recruiting
Advanced Research for Health Improvement LLC
Naples, Florida · Withdrawn
Midwest Heart and Vascular Spec
Overland Park, Kansas · Recruiting
Tufts Medical Center
Boston, Massachusetts · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Brigham and Womens Hosp Harvard Med School
Boston, Massachusetts · Recruiting
Brigham and Womens Hosp Harvard Med School
Boston, Massachusetts · Recruiting
Henry Ford Hospital
Detroit, Michigan · Recruiting
Henry Ford Hospital
Detroit, Michigan · Recruiting
AA Medical Research Center
Flint, Michigan · Recruiting
William Beaumont Hospital
Royal Oak, Michigan · Recruiting
Minneapolis Heart Institute
Minneapolis, Minnesota · Withdrawn
University Of Minnesota
Minneapolis, Minnesota · Recruiting
Overlook Medical Center
Summit, New Jersey · Recruiting
Capital Cardiology Associates
Albany, New York · Recruiting
New York Presbyterian Hospital
New York, New York · Active not recruiting
Icahn School of Med at Mt Sinai
New York, New York · Recruiting
Strong Memorial Hospital
Rochester, New York · Recruiting
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina · Recruiting
Lindner Ctr At The Christ Hosp
Cincinnati, Ohio · Recruiting
Ohio State University
Columbus, Ohio · Withdrawn
Perelman School of Medicine
Philadelphia, Pennsylvania · Recruiting
Texas Heart Institute
Houston, Texas · Recruiting
Orion Medical
Houston, Texas · Recruiting
Virginia Heart
Falls Church, Virginia · Recruiting
Carient Heart and Vascular
Manassas, Virginia · Recruiting
Novartis Investigative Site
Linz, Austria · Withdrawn
Novartis Investigative Site
Vienna, Austria · Recruiting
Showing 40 of 140 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.